JMP Securities started coverage on shares of Blend Labs (NYSE:BLND - Free Report) in a research report sent to investors on Wednesday, MarketBeat.com reports. The firm issued an outperform rating and a $7.00 price objective on the stock.
A number of other equities research analysts have also recently weighed in on BLND. Wells Fargo & Company increased their price target on Blend Labs from $4.50 to $6.50 and gave the company an "overweight" rating in a research note on Thursday, December 5th. Keefe, Bruyette & Woods lifted their target price on shares of Blend Labs from $3.25 to $3.85 and gave the stock a "market perform" rating in a report on Thursday, November 7th. The Goldman Sachs Group upped their price target on shares of Blend Labs from $3.40 to $3.90 and gave the company a "buy" rating in a research note on Thursday, November 7th. UBS Group raised their price objective on shares of Blend Labs from $3.00 to $4.00 and gave the stock a "neutral" rating in a research report on Wednesday, October 23rd. Finally, Canaccord Genuity Group upped their target price on Blend Labs from $4.75 to $5.75 and gave the company a "buy" rating in a research report on Thursday, November 7th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $5.11.
Read Our Latest Stock Report on Blend Labs
Blend Labs Price Performance
NYSE BLND traded down $0.34 during trading on Wednesday, reaching $4.70. 3,521,624 shares of the company's stock were exchanged, compared to its average volume of 2,375,040. The business has a 50 day moving average price of $4.41 and a 200-day moving average price of $3.59. The stock has a market capitalization of $1.20 billion, a P/E ratio of -13.82 and a beta of 1.33. Blend Labs has a fifty-two week low of $2.08 and a fifty-two week high of $5.53.
Insiders Place Their Bets
In related news, Director Timothy J. Mayopoulos sold 42,721 shares of the firm's stock in a transaction on Wednesday, November 20th. The stock was sold at an average price of $5.00, for a total value of $213,605.00. Following the transaction, the director now owns 387,620 shares in the company, valued at approximately $1,938,100. This trade represents a 9.93 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Winnie Ling sold 20,000 shares of the business's stock in a transaction dated Thursday, October 10th. The shares were sold at an average price of $3.43, for a total value of $68,600.00. Following the completion of the transaction, the insider now directly owns 259,169 shares of the company's stock, valued at approximately $888,949.67. This trade represents a 7.16 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 211,838 shares of company stock worth $1,050,644 in the last quarter. Corporate insiders own 13.21% of the company's stock.
Institutional Investors Weigh In On Blend Labs
A number of large investors have recently bought and sold shares of the company. FMR LLC increased its stake in shares of Blend Labs by 15.8% in the 3rd quarter. FMR LLC now owns 26,148 shares of the company's stock valued at $98,000 after purchasing an additional 3,576 shares during the last quarter. ClariVest Asset Management LLC raised its stake in Blend Labs by 2.9% during the second quarter. ClariVest Asset Management LLC now owns 252,059 shares of the company's stock worth $595,000 after acquiring an additional 6,988 shares in the last quarter. Dark Forest Capital Management LP bought a new position in shares of Blend Labs in the second quarter worth about $31,000. Xponance Inc. acquired a new stake in shares of Blend Labs in the 2nd quarter valued at approximately $35,000. Finally, EP Wealth Advisors LLC boosted its stake in shares of Blend Labs by 8.2% in the 2nd quarter. EP Wealth Advisors LLC now owns 212,841 shares of the company's stock valued at $502,000 after purchasing an additional 16,084 shares in the last quarter. 52.56% of the stock is currently owned by institutional investors and hedge funds.
About Blend Labs
(
Get Free Report)
Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.
Further Reading
Before you consider Blend Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blend Labs wasn't on the list.
While Blend Labs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.